Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients

Transplantation

Volumn 69, Issue 8, 2000, Pages 1582-1586

  Hammarstrom V ^a   Pauksen, K ^b   Svensson, H ^a   Lonnqvist B ^a   Simonsson, B ^b   Ringden O ^a   Ljungman, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MELPHALAN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; STREPTOCOCCUS INFECTION; TETANUS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE; TETANUS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034720060     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Allogeneic bone marrow transplantation
2. Immunologic reconstitution after human bone marrow grafting
3. Immune system reconstitution following allogeneic bone marrow transplantation in man: A multiparameter analysis
4. Studies of immunological reactivity following syngeneic or allogeneic graft in man
5. Immunocompetence following allogeneic bone marrow transplantation in man
6. Immunodeficiency following allogeneic bone marrow transplantation
7. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors
8. Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy
9. Efficacy and safety of vaccination of marrow transplant recipients with live attenuated measle, mumps and rubella vaccine
10. Immunity to and immunization against measles, rubella and mumps after autologous bone marrow transplantation
11. IgG subclass associated differences of specific antibodies in humans
12. IgG subclasses in bacterial infections
13. Active and passive tetanus immunization
14. The immunological basis for immunization. Module 3: Tetanus
15. Experience with a cooperative bone marrow transplantation program in Stockholm
16. Bone marrow transplantation
17. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
18. Chronic graft-versus-syndrome in man. A long time clinicopathologic study of 250 Seattle patients
19. Oral manifestations of chronic graft-v-host disease
20. High dose chemotherapy with autologous bone marrow transplantation in acute myeloid leukemia
21. Enzyme linked immunosorbent assay for subclass distribution IgG and IgA antigen-specific antibodies
22. Modification of ELISA for the estimation of tetanus antitoxin in human sera
23. The kinetics of immune reconstitution after human marrow transplantation
24. Reconstitution of B cell immunity following bone marrow transplantation
25. B cell reconstitution after human bone marrow transplantation: Recapitulation of ontogeny?
26. Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment
27. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation
28. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease
29. Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease
30. Tetanus immunity in patients with hematological malignancies
31. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation
32. Transfer of a functioning humoral immune system in transplantation of T lymphocyte-depleted bone marrow
33. Efficacy and safety of vaccination of marrow transplant recipients with live attenuated measles, mumps and rubella vaccine
34. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients